Home Biosimilar Antibodies Others Others Anti-KAAG1 (ADCT-901-MMAE) For research use only.
Not for use in humans.

Anti-KAAG1 (ADCT-901-MMAE)

Synonyms: ADCT-901

Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer. MW :145.28 KD.

Anti-KAAG1 (ADCT-901-MMAE)

CAS No.

Purity & Quality Control

≥99

Biological Activity

Description Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer. MW :145.28 KD.

Product Details

Molecular Weight 145.28
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Anti-KAAG1 (ADCT-901-MMAE) | Anti-KAAG1 (ADCT-901-MMAE) supplier | purchase Anti-KAAG1 (ADCT-901-MMAE) | Anti-KAAG1 (ADCT-901-MMAE) cost | Anti-KAAG1 (ADCT-901-MMAE) manufacturer | order Anti-KAAG1 (ADCT-901-MMAE) | Anti-KAAG1 (ADCT-901-MMAE) distributor